XYPHOS
Live / Registered — Registered (as of 28 Oct 2025)
What this means for you
Registered since 28 Oct 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Oct 2031: the §8 declaration of use).
Record
- Serial number
- 98280623
- Registration number
- 8005886
- Mark type
- Word mark
- Filed
- 21 Nov 2023
- Published for opposition
- 07 Jan 2025
- Registered
- 28 Oct 2025
- Next maintenance filing
- §8 declaration of use, due by 28 Oct 2031 (grace period to 28 Apr 2032)
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for treatment of cancer and viral-infected cells; pharmaceuticals in the nature of biologic agents for adoptive cellular therapy
Owner
- Xyphos Biosciences, Inc., South San Francisco, CA, US
- Xyphos Biosciences, Inc., South San Francisco, CA, US
- Xyphos Biosciences, Inc., South San Francisco, CA, US
Prosecution history
- 28 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2025 — USE AMENDMENT FILED
- 02 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 14 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED